Shalini L. Kulasingam, Assistant Professor
Ph.D.
A.B. Bryn Mawr College
M.P.H. University of California, Los Angeles
Ph.D. University of Washington, Seattle
Research Interests:
Human papillomavirus (HPV), cervical cancer, cancer screening, vaccines, public health policy, decision and cost-effectiveness modeling
Recent Publications:
| |
Baseman JG, Kulasingam SL, Harris TG, Hughes JP, Kiviat NB, Mao C, Koutsky LA. Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United States. Am J Obstet Gynecol. 2008;199:26.e1-8.
Havrilesky LJ, Secord AA, Darcy KM, Armstrong DK, Kulasingam S; Gynecologic Oncology Group. Cost effectiveness of intraperitoneal compared with intravenous chemotherapy for women with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol. 2008;26:4144-50.
Kulasingam SL, Bernard S, Barnabas RV, Largeron N, Myers ER. Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: a cost-effectiveness analysis. Cost Effectiveness and Resource Allocation. 2008;6:4-
Kulasingam SL, Pagliusi S, Myers ER. Potential implications of non-adherence with cervical cancer screening in the era of HPV vaccination. Vaccine, 2007;25:8110-3
Jewel E, Kulasingam SL, Myers ER, Secord AA, Havrilesky L. Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis. Gyn Oncology, 2007;107:532-40
Havrilesky L, Secord AA, Kulasingam SL, Myers ER. Management of platinum-sensitive recurrent ovarian cancer: a cost-effectiveness analysis. Gyn Oncology.2007 107:211-8
Kulasingam SL, Connolly L, Conway L, et al. The cost-effectiveness of adding an HPV vaccine to cervical cancer screening in Australia. Sexual Health, 2007;4:165-7
Kulasingam SL. Implementation of a successful human papillomavirus program. Disease Management and Outcomes. 2007;15:141-149
Barnabas RV, Kulasingam SL. Economic Evaluations of human papillomavirus vaccines. Expert Review of Pharmacoeconomics and Outcomes Research, 2007;7:251-267
|
|
Professional Experience:
| |
2008-Present Assistant Professor, Department of Epidemology and Community Health, University of Minnesota, MN
2006-2008 Assistant Professor, Department of Obstetrics and Gynecology
2004-2008 Senior Fellow, Duke Center for Clinical Health Policy and Research, Duke University, NC
2004-2006 Research Assistant Professor, Department of Obstetrics and Gynecology, Duke University, NC
2001-2004 Fellow, Duke Center for Clinical Health Policy and Research, Duke University, NC
2001-2004 Research Associate, Department of Obstetrics and Gynecology, Duke University, NC |
|
Mailing Address:
West Bank Office Building
1300 S. Second Street, Suite 300
Minneapolis, MN 55454
Phone:(612) 612-624-7554
Email: kulas016
Office:
|
Link
to: Academic Health Center : School
of Public Health : U of M Home 
